본문 바로가기
KERD
논문KCI 등재

Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: This study aimed to analyze the treatment outcomes of locally recurrent nasopharyngeal cancer (NPC) patients following moderate hypo-fractionation re-irradiation (re-RT). Materials and methods: Sixty locally recurrent NPC patients underwent hypo-fractionation re-RT. Forty-eight point three percentage had rT3-4, and 30.0% did keratinizing squamous cell carcinoma. Intensity-modulated radiation therapy (IMRT), with or without intensity-modulated proton therapy (IMPT), was used in 66.7% of patients. Results: With the median follow-up of 22 months (range, 2 to 254 months), 31 patients (51.7%) died, 38 (63.3%) developed further treatment failure, and 30 (50.0%) developed ≥ grade 3 toxicity (including seven grade 5) at time of analysis. The 2- and 5-year rates of overall survival, local failure-free survival, and ≥ grade 3 toxicity-free survival were 57.9% and 45.8%, 64.1% and 52.5%, and 54.8% and 44.9%, respectively. In multivariate analyses, worse factors for overall survival (OS) were iT3-4 (p=0.010) and age at re-RT ≥ 53 years (p=0.003), those for local failure-free survival (LFFS) were rT3-4 (p=0.022) and rN0-1 (p=0.035), and those for toxicity-free survival (TFS) were iT3-4 (p=0.020) and re-IMRT/IMPT (p=0.030), respectively. Cumulative dose or fraction size ≥ 3 Gy at re-RT, however, showed no significance for OS, LFFS and TFS. Conclusion: Current re-RT with modern RT techniques by moderate hypo-fractionation scheme seemed feasible in treating locally recurrent NPC patients.

Abstract

Purpose: This study aimed to analyze the treatment outcomes of locally recurrent nasopharyngeal cancer (NPC) patients following moderate hypo-fractionation re-irradiation (re-RT). Materials and methods: Sixty locally recurrent NPC patients underwent hypo-fractionation re-RT. Forty-eight point three percentage had rT3-4, and 30.0% did keratinizing squamous cell carcinoma. Intensity-modulated radiation therapy (IMRT), with or without intensity-modulated proton therapy (IMPT), was used in 66.7% of patients. Results: With the median follow-up of 22 months (range, 2 to 254 months), 31 patients (51.7%) died, 38 (63.3%) developed further treatment failure, and 30 (50.0%) developed ≥ grade 3 toxicity (including seven grade 5) at time of analysis. The 2- and 5-year rates of overall survival, local failure-free survival, and ≥ grade 3 toxicity-free survival were 57.9% and 45.8%, 64.1% and 52.5%, and 54.8% and 44.9%, respectively. In multivariate analyses, worse factors for overall survival (OS) were iT3-4 (p=0.010) and age at re-RT ≥ 53 years (p=0.003), those for local failure-free survival (LFFS) were rT3-4 (p=0.022) and rN0-1 (p=0.035), and those for toxicity-free survival (TFS) were iT3-4 (p=0.020) and re-IMRT/IMPT (p=0.030), respectively. Cumulative dose or fraction size ≥ 3 Gy at re-RT, however, showed no significance for OS, LFFS and TFS. Conclusion: Current re-RT with modern RT techniques by moderate hypo-fractionation scheme seemed feasible in treating locally recurrent NPC patients.

참고문헌 (30)

  1. Lee AW, "Management of nasopharyngeal carcinoma : current practice and future perspective", J Clin Oncol, 33, pp.3356~3364 (2015)
  2. Coatesworth AP, "The cause of death in patients with head and neck squamous cell carcinoma", J Laryngol Otol, 116, pp.269~271 (2002)
  3. Lee AWM, "Management of locally recurrent nasopharyngeal carcinoma", Cancer Treat Rev, 79, pp.101890~ (2019)
  4. Chan OS, "Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma", Head Neck, 39, pp.533~540 (2017)
  5. Dionisi F, "Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma", Acta Oncol, 58, pp.1238~1245 (2019)
  6. Hua YJ, "Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy", Eur J Cancer, 48, pp.3422~3428 (2012)
  7. Ng WT, "Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma", Head Neck, 42, pp.180~187 (2020)
  8. Yue Q, "Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy : a meta-analysis", Oral Oncol, 81, pp.81~88 (2018)
  9. Leong YH, "Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy : a meta-analysis", Head Neck, 40, pp.622~631 (2018)
  10. Alfonso JCL, "Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy", Radiat Oncol, 14, pp.88~ (2019)
  11. Quan K, "Toxicities following stereotactic ablative radiotherapy treatment of locally-recurrent and previously irradiated head and neck squamous cell carcinoma", Semin Radiat Oncol, 26, pp.112~119 (2016)
  12. 조원경, "Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients", Cancer Research and Treatment, 51(2), pp.603~610 (2019), 대한암학회
  13. Zhang B, "Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma : a systematic review and meta-analysis", Oral Oncol, 51, pp.1041~1046 (2015)
  14. Li YQ, "Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy", J Clin Oncol, 36, pp.891~899 (2018)
  15. Lin R, "Nasopharyngeal carcinoma : repeat treatment with conformal proton therapy : dose-volume histogram analysis", Radiology, 213, pp.489~494 (1999)
  16. Hu J, "Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma : Initial results", Cancer, 124, pp.2427~2437 (2018)
  17. Schwaibold F, "The effect of fraction size on control of early glottic cancer", Int J Radiat Oncol Biol Phys, 14, pp.451~454 (1988)
  18. Le QT, "Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma", Int J Radiat Oncol Biol Phys, 39, pp.115~126 (1997)
  19. Lee AW, "Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 46, pp.865~872 (2000)
  20. Tian YM, "Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy : a phase 2, single-center, randomized controlled trial", Cancer, 120, pp.3502~3509 (2014)
  21. Leung TW, "Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 75, pp.734~741 (2009)
  22. Ozyigit G, "A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 81, pp.e263~e268 (2011)
  23. Seo Y, "Robotic system-based fractionated stereotactic radiotherapy in loca-lly recurrent nasopharyngeal carcinoma", Radiother Oncol, 93, pp.570~574 (2009)
  24. Stelow EB, "Update from the 4th edition of the World Health Organization classification of head and neck tumours : nasopharynx", Head Neck Pathol, 11, pp.16~22 (2017)
  25. Ou SI, "Epidemiology of nasopharyngeal carcinoma in the United States : improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology", Ann Oncol, 18, pp.29~35 (2007)
  26. Fandi A, "Biology and treatment of nasopharyngeal cancer", Curr Opin Oncol, 7, pp.255~263 (1995)
  27. Reddy SP, "Prognostic significance of keratinization in nasopharyngeal carcinoma", Am J Otolaryngol, 16, pp.103~108 (1995)
  28. Yang K, "Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients", Oral Oncol, 114, pp.105180~ (2021)
  29. Li XY, "The development of a nomogram to predict post-radiation necro-sis in nasopharyngeal carcinoma patients : a large-scale cohort study", Cancer Manag Res, 11, pp.6253~6263 (2019)
  30. 신성수, "High Dose 3-Dimensional Re-Irradiation for Locally Recurrent Nasopharynx Cancer", Yonsei Medical Journal, 45(1), pp.100~106 (2004), 연세대학교의과대학

관련 논문AI추천

Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707)김명수, 김성현, 김연실, 김태형, 김현주, 박재원, 이정심, 이창걸대한암학회 · Cancer Research and Treatment2020 · 제52권 제4호Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients김태규, 남희림, 노재명, 안용찬, 오동렬, 이언주, 이혜빈, 조원경대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer남희림, 노재명, 박수연, 안용찬, 오동률, 이혜빈대한암학회 · Cancer Research and Treatment2016 · 제48권 제2호Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-upBoyu Chen, Chong Zhao, Fei Han, Huageng Huang, Jingjing Miao, Lin Wang, Manyi Zhu, Shaomin Huang, Weiwei Xiao, Weixiong Xia, Xiang Guo, Xiaowu Deng, Xiao Xiao, Xing Lv, Yanqun Xiang, Yinglin Peng, Yingshan Liang대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaDehuan Xie, Jiang Hu, Lei Wang, Ruifang Zeng, Rui Zhong, Shaomin Huang, Shu Zhou, Wanqin Cheng, Yong Su, Zheng Wu대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea강진형, 김민식, 김범수, 김연실, 김훈교, 문성권, 선동일, 유은정, 윤세철, 이연수, 정소령, 정수미, 조승호대한암학회 · Cancer Research and Treatment2008 · 제40권 제4호

이 간행물의 다른 논문 (29건)

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group김효송, 천재경, 임선민, 윤지나, 장대영, 차용준, 강진형, 박인근, 이인희, 김한상, 홍용상, 장세진, 윤홍석, 안희경, 윤신교, 김태원, 유창훈, 김인호, 김지현, 김진원, 김지훈, 김승태, 김미소, 정재호pp. 1-9Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors윤정희, 임지현, 조주희, 남희수, 이만경, 복혜숙, 이상원, 김수연, 강은지, 안진석, 오동렬, 신수용, 김영하, 강단비, 심성근pp. 10-19Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea김달용, Dae Seog Heo, 임채만, 유신혜, 신성준, 김도연, Min Sun Kim, 이현정, 서세영, 임지연pp. 20-29Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations신상원, 임승택, 장원진, 박경화, 이종원, 강은주, 조성심, 김정선, 임태규, 김혜숙, 김유정, 이수현, 최정윤, 김주원, 조장호, 안미선, 임아름, 김영생, 박지현, 이영우, 정희준, 김열홍, 최윤지, 성재숙pp. 30-39Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue박지현, 안원균, 노재명, 표홍렬, 박웅양, 이호연, 김연정, 최창훈, 이태섭, 박동현pp. 40-53